CSTL — Castle Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for Castle Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	330	259	243	293	300
Net Total Accounts Receivable
Net Total Receivables	17.3	23.5	38.3	51.2	43.4
Total Inventory
Prepaid Expenses
Total Current Assets	354	292	296	360	361
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	16.9	26.5	37.7	62.7	112
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	463	447	453	531	579
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	24.9	36.1	47.7	49.4	68.7
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	50.8	48.2	62.1	75.4	108
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	412	399	391	456	471
Total Liabilities & Shareholders' Equity	463	447	453	531	579
Total Common Shares Outstanding